Skip to content

Clinical trials

Phase 4 Neurotoxicity Syndromes trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurotoxicity Syndromes Phase: Phase 4 Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20141
20151
20181
20201
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Unknown status2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GERCOR - Multidisciplinary Oncology Cooperative Group1
HealthPartners Institute1
Mansoura University1
Medical University of South Carolina1
Oncologia Medica dell'Ospedale Fatebenefratelli1
University of British Columbia1
University of California, Davis1
Vanderbilt University Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurotoxicity Syndromes8
Breast Neoplasms2
Drug-Related Side Effects and Adverse Reactions2
Anus Neoplasms1
Appendiceal Neoplasms1
Bile Duct Neoplasms1
Carcinoma, Hepatocellular1
Colonic Neoplasms1
Esophageal Neoplasms1
Gallbladder Neoplasms1

Trials

Showing 76 to 8 of 8. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.